About Nova In Silico
Nova In Silico is a company based in Lyon (France) founded in 2010 by Francois Henri Boissel. Nova In Silico offers products and services including jinkō Platform. Nova In Silico operates in a competitive market with competitors including MetricWire, Trials.ai, HeartcoR, Strategikon Pharma and VersaTrial, among others.
- Headquarter Lyon, France
- Founders Francois Henri Boissel
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$309.85 K (USD), Grant
Sep 01, 2015
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nova In Silico
Nova In Silico offers a comprehensive portfolio of products and services, including jinkō Platform.
Tool for predicting clinical trial outcomes using digital patients.
Funding Insights of Nova In Silico
Investments & Acquisitions by Nova In Silico
Investment portfolio details for Nova In Silico
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nova In Silico
Detailed financials for Nova In Silico
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nova In Silico Comparisons
Peer comparison for Nova In Silico
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nova In Silico
Nova In Silico operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MetricWire, Trials.ai, HeartcoR, Strategikon Pharma and VersaTrial, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Online platform for researchers to collect data via the smartphone.
|
|
| Locked | Locked | Locked |
Provider of AI based trial management solution.
|
|
| Locked | Locked | Locked |
Provides expert ECG recording and analysis for clinical research safety studies.
|
|
| Locked | Locked | Locked |
Provides SaaS tools for streamlining clinical trial budgeting and vendor oversight.
|
|
| Locked | Locked | Locked |
Software solutions for clinical trial study design implementation are provided.
|
|
| Locked | Locked | Locked |
AI-based tools for designing and programming scientific experiments are provided.
|
Detailed competitors of Nova In Silico
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nova In Silico
Complete news archive for Nova In Silico
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nova In Silico
Nova In Silico was founded in 2010 and raised its 1st funding round 5 years after it was founded.
Nova In Silico is headquartered in Lyon, France. It is registered at Lyon, Auvergne-rhone-alpes, France.
Francois Henri Boissel is the current CEO of Nova In Silico. They have also founded this company.
Nova In Silico was founded in 2010 in Lyon, France, as a developer of AI technologies focused on biology, medicine, and data science. The companys platform, Jinko, is utilized to simulate clinical trials through disease models and digital patient representations. Operations center on streamlining trial processes to support decision-making, with services provided in the biotech and AI sectors across Europe.
Nova In Silico's top competitors include MetricWire, Trials.ai and AnalysisMode.
Nova In Silico offers jinkō Platform.